NCT06884930

Brief Summary

Infertility, as defined by the World Health Organization (WHO), is a disorder of the male or female reproductive system characterized by the inability to achieve a clinical pregnancy after 12 months or more of regular, unprotected sexual intercourse. In modern fertility treatment, assisted reproductive technologies (ART), including in vitro fertilization (IVF), have become a standard approach for addressing complex fertility issues and sterility. In Italy, infertility affects approximately 16.5% of couples. Despite advancements in ART, comparing the failure rates of pregnancies achieved through ART with those of spontaneous pregnancies in Italy reveals significant differences, particularly in terms of success rates, miscarriage rates, and embryo implantation outcomes. In this context, AI-based models have shown promising potential in predicting IVF success by analyzing complex datasets that include patient demographics, hormonal levels, and embryo morphology. Research indicates that AI can enhance embryo selection, predict the optimal timing for embryo transfer, and advance personalized medicine approaches in reproductive health. This study aims to use of Machine Learning to identify patterns and factors associated with successful pregnancy outcomes by analyzing large-scale, anonymized ART data. The resulting predictive model could enable clinicians to better personalize treatment protocols for each patient, optimizing medication dosages, timing, and embryo selection. It could also improve pregnancy success rates while reducing the emotional and financial burden on patients, thus advancing the standard of care in ART.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 19, 2025

Completed
28 days until next milestone

Study Start

First participant enrolled

April 16, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

October 7, 2025

Status Verified

October 1, 2025

Enrollment Period

11 months

First QC Date

March 13, 2025

Last Update Submit

October 2, 2025

Conditions

Keywords

IVFMachine Learning-based Predictive Modelpregnancy

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    The primary endpoint of the study will be the clinical pregnancy defined as a pregnancy confirmed by an increasing level of hCG and the presence of a gestational sac or heartbeat detected by ultrasound.

    Data will be extracted for all ART cycles conducted between 2019 and 2024 to allow for the comprehensive development of the Machine Learning-based model.

Study Arms (1)

IVF patients

Eligibility Criteria

Age18 Years - 43 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Couples who received IVF treatment between 2019 and 2024

You may qualify if:

  • Patients who underwent ART procedures, including IVF and ICSI, between 2019 and 2024.
  • Women aged between 18 and 43 years.

You may not qualify if:

  • Patiens with incomplete or missing data records that do not provide sufficient information for analysis.
  • women outside the 18 to 43 age range

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Raffaele Hospital

Milan, Milano, 20132, Italy

Location

Related Publications (5)

  • Zhang Q, Liang X, Chen Z. A review of artificial intelligence applications in in vitro fertilization. J Assist Reprod Genet. 2025 Jan;42(1):3-14. doi: 10.1007/s10815-024-03284-6. Epub 2024 Oct 14.

  • Jiang VS, Bormann CL. Artificial intelligence in the in vitro fertilization laboratory: a review of advancements over the last decade. Fertil Steril. 2023 Jul;120(1):17-23. doi: 10.1016/j.fertnstert.2023.05.149. Epub 2023 May 19.

  • Attività del Registro Nazionale Italiano della Procreazione Medicalmente Assistita - 17° Report 2021

    RESULT
  • European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE); Smeenk J, Wyns C, De Geyter C, Kupka M, Bergh C, Cuevas Saiz I, De Neubourg D, Rezabek K, Tandler-Schneider A, Rugescu I, Goossens V. ART in Europe, 2019: results generated from European registries by ESHREdagger. Hum Reprod. 2023 Dec 4;38(12):2321-2338. doi: 10.1093/humrep/dead197.

  • Infertility prevalence estimates, 1990-2021. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.

    RESULT

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 13, 2025

First Posted

March 19, 2025

Study Start

April 16, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

October 7, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations